Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 48,300 shares, a growth of 11,975.0% from the September 30th total of 400 shares. Based on an average daily trading volume, of 1,450,400 shares, the short-interest ratio is presently 0.0 days.
Oncotelic Therapeutics Trading Up 1.7 %
Shares of OTLC traded up $0.00 on Friday, hitting $0.04. 106,288 shares of the stock traded hands, compared to its average volume of 148,917. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.01 and a current ratio of 0.01. The stock’s 50 day moving average is $0.02 and its two-hundred day moving average is $0.03. Oncotelic Therapeutics has a 1 year low of $0.02 and a 1 year high of $0.05.
About Oncotelic Therapeutics
See Also
- Five stocks we like better than Oncotelic Therapeutics
- With Risk Tolerance, One Size Does Not Fit All
- Texas Roadhouse Stock Steering for New Highs This Year
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- The 3 Best Fintech Stocks to Buy Now
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Oncotelic Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncotelic Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.